Mar 5 |
Monopar Announces Positive Preclinical Therapeutic Isotope Data for its MNPR-101 Radiopharma Program
|
Feb 27 |
Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical Trial
|
Feb 27 |
Here's Why We're Watching Monopar Therapeutics' (NASDAQ:MNPR) Cash Burn Situation
|
Feb 22 |
Dow Gains Over 400 Points; Keurig Dr Pepper Shares Fall After Q4 Results
|
Feb 22 |
What's Going On With Cancer-Focused Monopar Therapeutics Stock Today?
|
Feb 22 |
Monopar stock jumps 60% amid preclinical data for MNPR-101
|
Feb 22 |
Monopar Announces Promising Preclinical Data for its MNPR-101 Radiopharma Program Targeting Advanced Cancers
|
Feb 20 |
Monopar Receives Clearance to Proceed with First-in-Human Phase 1 Trial of Novel Radiopharmaceutical MNPR-101-Zr in Advanced Cancers
|
Nov 9 |
Monopar Therapeutics GAAP EPS of -$0.14 beats by $0.03
|
Nov 9 |
Monopar Therapeutics Inc Reports Q3 2023 Financial Results and Progress in Clinical Programs
|